Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain

机译：白藜芦醇与口服避孕药联合治疗子宫内膜异位症相关疼痛的优势

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe effect of resveratrol on the management of endometriosis-related pain was investigated in 12 patients who failed to obtain pain relief during use of an oral contraceptive containing drospirenone + ethinylestradiol.

机译：背景研究了白藜芦醇对子宫内膜异位症相关疼痛管理的影响，该研究针对12名在使用含屈螺酮+炔雌醇的口服避孕药期间未能减轻疼痛的患者。

著录项

期刊名称 International Journal of Womens Health
作者
Hugo Maia Jr; Clarice Haddad; Nathanael Pinheiro; Julio Casoy;
展开▼
作者单位

展开▼
年(卷),期 2012(4),-1
年度 2012
页码 543–549
总页数 7
原文格式 PDF
正文语种
中图分类
关键词
resveratrol drospirenone endometriosis dysmenorrhea cyclo-oxygenase-2;

机译：白藜芦醇;屈螺酮;子宫内膜异位;痛经;环氧合酶-2;

相似文献

外文文献
中文文献
专利

1. Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain [J] . Hugo Maia Jr, Clarice Haddad, Nathanael Pinheiro, International Journal of Women s Health . 2012,第1期

机译：白藜芦醇与口服避孕药联合治疗子宫内膜异位症相关疼痛的优势
2. Combining oral contraceptives with a natural nuclear factor-kappa B inhibitor for the treatment of endometriosis-related pain [J] . Hugo Maia Jr, Clarice Haddad, Julio Casoy International Journal of Women s Health . 2014,第5期

机译：结合口服避孕药和天然核因子-κB抑制剂治疗子宫内膜异位症相关疼痛
3. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. [J] . Seracchioli R, Mabrouk M, Frasca C, Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society . 2010,第2期

机译：长期口服避孕药和腹腔镜手术切除子宫内膜异位症后的术后疼痛处理：一项随机对照试验。
4. Menstrual irregularity and compliance in contraception: comparison between oral contraceptives and etonogestrel contraceptive implant [C] . Alexandra Bermudez, Mario Muniz, Luis Ruvalcaba, World Congress on Fertility and Sterility . 2004

机译：避孕的月经不规则和遵守：口服避孕药和Etonogestrel避孕药之间的比较
5. Maternal Exposure to Different Types of Hormonal Compounds from Oral Contraceptives in the First Trimester of Pregnancy and Its Association with Birth Defects. [D] . Ahmed, Makhdum. 2017

机译：孕早期孕妇从口服避孕药中接触不同类型的激素化合物，并且与出生缺陷有关。
6. Combining oral contraceptives with a natural nuclear factor-kappa B inhibitor for the treatment of endometriosis-related pain [O] . Hugo Maia Jr, Clarice Haddad, Julio Casoy 2014

机译：结合口服避孕药和天然核因子-κB抑制剂治疗子宫内膜异位症相关疼痛
7. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary A report of the american college of cardiology/american heart association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure) developed in collaboration with the international society for heart and lung transplantation endorsed by the heart failure society of america51The document was approved by the American College of Cardiology Board of Trustees in November 2001 and the American Heart Association Science Advisory and Coordinating Committee in September 2001.52When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2101–13.53The American College of Cardiology and the American Heart Association make every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing panel at the first meeting, and updated as changes occur.54This document, as well as the corresponding full-text guidelines, is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Single reprints of the executive summary are available for $5.00 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org (specify version: Executive Summary—71-0125; Full Text—71-1026).55© 2001 American College of Cardiology and American Heart Association, Inc. [O] . Hunt Sharon A, Baker David W, Chin Marshall H, 2001

机译：ACC / AHA成人慢性心力衰竭评估和管理指南：执行摘要美国心脏病学会/美国心脏协会实践指南工作组的报告（委员会修订1995年心脏评估和管理指南与美国心力衰竭学会认可的国际心脏和肺移植协会合作51）该文件于2001年11月获得美国心脏病学会理事会的批准，并于2001年9月获得美国心脏协会科学咨询和协调委员会的批准.52引用本文件时，美国心脏病学会和美国心脏协会将赞赏以下引用格式：Hunt SA，Baker DW，Chin MH，Cinquegrani MP，Feldman AM，Francis GS，Ganiats TG，Goldstein S，Gregoratos G，Jessup ML，Noble RJ，Packer M，Silver MA，Stevenson LW。 ACC / AHA成人慢性心力衰竭评估和管理指南：摘要：美国心脏病学会/美国心脏协会实践指南工作组的报告（修订1995年《美国心脏病学会评估和管理指南》的委员会心脏衰竭）。 J Am Coll Cardiol 2001; 38：2101–13.53美国心脏病学会和美国心脏协会竭尽全力避免由于外部关系或个人，专业或其他原因而引起的任何实际或潜在的利益冲突。写作小组成员的商业利益。具体而言，要求写作小组的所有成员提供所有可能被视为实际或潜在利益冲突的关系的披露声明。这些声明由上级工作组审查，在第一次会议上口头报告给写作小组的所有成员，并在发生变化时进行更新。54本文档以及相应的全文指南可在万维网上找到。美国心脏病学院（www.acc.org）和美国心脏协会（www.americanheart.org）的网站。致电800-253-4636（仅适用于美国）或写信给美国心脏病，教育服务学院，地址为9111 Old Georgetown Road，Bethesda，MD 20814-1699，可以执行摘要的单个重印本，每张5.00美元。要购买最多999份的其他重印本，请致电800-611-6083（仅限美国）或传真413-665-2671； 1000或更多副本，请致电214-706-1466，传真214-691-6342或电子邮件pubauth@heart.org（指定版本：执行摘要-71-0125；全文-71-1026）。55©2001美国心脏病学会和美国心脏协会有限公司

Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain

摘要

著录项

相似文献

相关主题

期刊订阅